We are conducting a cross-sectional, case-controlled study of energy expenditure in subjects with narcolepsy, who will be individually matched with healthy controls. ? The primary objectives of this study is to determine whether hypocretin-deficient subjects with narcolepsy have lower energy expenditure as determined by a 24h stay in the metabolic chamber. ? ? During an inpatient visit of approximately 3 weeks following screening and medication washout the following additional parameters will be assessed: physical activity (by doubly labeled water study and activity monitors); food intake (dietary history, experimental in-house buffet and food vending machines with computerized access code), body composition (dexa measurements and abdomen CT); measurements of cutaneous and core body temperature and heart rate variability, both indirect indices of autonomic nervous system activity. Endocrine in-depth characterization will include insulin resistance (oral and iv glucose tolerance test), leptin and gh-relin levels as well as characterization of the main neuroendocrine axes.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2008
Total Cost
$387,112
Indirect Cost
City
State
Country
United States
Zip Code
Cizza, Giovanni; Skarulis, Monica; Mignot, Emmanuel (2005) A link between short sleep and obesity: building the evidence for causation. Sleep 28:1217-20
Marques-Deak, A; Cizza, G; Sternberg, E (2005) Brain-immune interactions and disease susceptibility. Mol Psychiatry 10:239-50
Cizza, G; Romagni, P; Lotsikas, A et al. (2005) Plasma leptin in men and women with seasonal affective disorder and in healthy matched controls. Horm Metab Res 37:45-8
Eskandari, Farideh; Mistry, Sejal; Martinez, Pedro E et al. (2005) Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism 54:918-24
Bloch, Miki; Rubinow, David R; Schmidt, Peter J et al. (2005) Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. J Clin Endocrinol Metab 90:695-9
Fox, Stephen D; Roman, John M; Cizza, Giovanni et al. (2005) Quantitative determination of antalarmin, a novel corticotropin-releasing hormone receptor-1 antagonist, in canine plasma by HPLC-MS. J Sep Sci 28:332-6
Ayala, Alejandro R; Pushkas, Judy; Higley, J Dee et al. (2004) Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm. J Clin Endocrinol Metab 89:5729-37